Contact this trialFirst, we need to learn more about you.
HER2 Inhibitor
BAY2927088 for Cancer
Recruiting1 awardPhase 2
Duarte, California
This trial is testing a new drug called BAY2927088 in people with solid tumors that have specific mutations in a gene called HER2. The drug is expected to block abnormal proteins in cancer cells
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.